Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution via Diastereomeric Salt Formation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105820113B reveals a novel resolution method for Crizotinib intermediates offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN101659623A details a novel chemical resolution for leucine and isoleucine using DBTA, offering high purity and recyclable agents for reliable supply chains.
Patent CN100336803C details a scalable resolution method for difluorophenylalanine, offering high purity and cost-effective supply chain solutions for pharma.
Patent CN1197447A discloses a robust method for resolving racemates like selegiline and ephedrine using stable phenoxypropionic acid derivatives, offering high purity and scalable manufacturing advantages.
Patent CN102010327B details a cost-effective resolution method for S-(+)-Ketoprofen using a novel amine resolving agent, ensuring high optical purity and scalable manufacturing for pharmaceutical supply chains.
Advanced chiral resolution technology for 2-heterocyclic dihydropyrimidines using binaphthol phosphate. Delivers >99% optical purity for scalable hepatitis B drug manufacturing.
Patent CN102417497A reveals a novel resolution method for Ramelteon intermediates, offering high optical purity and significant cost reduction in pharmaceutical manufacturing.
Patent CN1128785C reveals a novel two-step resolution process for high-purity 1-phenylethylamines, offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN118026867B details a high-efficiency chiral resolution for Mirogabalin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN102050800A details a cost-effective chiral resolution method for antidepressant intermediates, replacing complex asymmetric synthesis with scalable salt formation.
Patent CN1309121A details efficient chiral resolution of antihistamine intermediates using DPTTA, offering high purity and scalable manufacturing for global supply chains.
Patent CN101142211B details a robust resolution process for cis-oxathiolane cytosine derivatives, offering significant cost reduction and supply chain reliability for antiviral API manufacturing.
Patent CN102070469A reveals chiral cyclic phosphoric acid resolution for high-purity metoprolol. Significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102321040A details a low-cost resolution method for Linezolid intermediates using chiral acids, offering significant supply chain advantages for API manufacturers.
Patent CN109232220B details a novel chiral resolution method offering high purity and scalable production for pharmaceutical intermediate supply chains.
Novel resolution method using L-Tyrosine methyl ester achieves >99.5% ee. Cost-effective, scalable process for pharmaceutical intermediates.
Patent CN100546969C details a cost-effective resolution method for 2-hydroxymethyl-3-phenylpropionic acid using N-Octylglucamine, offering high optical purity for pharmaceutical synthesis.